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Hypertensive	  diseases	  of	  pregnancy	  are	  considered	  to	  be	  common	  causes	  of	  maternal	  
deaths	  world	  wide	  [1].	  Of	  all	  pregnancies	  7	  to	  9	  percent	  	  are	  complicated	  by	  hypertension.	  
About	  1%	  of	  pregnancies	  are	  complicated	  by	  preexisting	  hypertension,	  5%	  to	  6%	  by	  
gestational	  hypertension	  without	  proteinuria	  (half	  of	  which	  presents	  preterm),	  and	  2%	  by	  
preeclampsia	  [2].	  In	  2008,	  358,000	  women	  died	  during	  or	  following	  pregnancy	  and	  childbirth.	  
Almost	  all	  of	  these	  deaths	  (99%)	  occurred	  in	  developing	  countries	  and	  most	  could	  have	  been	  
prevented	  [3].	  	  Nearly	  80%	  of	  the	  maternal	  deaths	  are	  caused	  by	  the	  five	  direct	  obstetric	  
causes	  namely	  haemorrhage,	  hypertension,	  sepsis,	  obstructed	  labour	  and	  complications	  of	  
abortion,	  see	  Figure	  1.	  Hypertension	  in	  pregnancy	  (preeclampsia	  and	  eclampsia)	  contributes	  
to	  18%	  of	  the	  deaths,	  being	  the	  second	  after	  hemorrhage	  as	  the	  most	  common	  cause	  of	  
maternal	  deaths.	  Apart	  from	  causing	  mortality	  preeclampsia	  and	  eclampsia	  are	  associated	  
with	  severe	  maternal	  and	  perinatal	  morbidity	  like	  intrauterine	  growth	  retardation,	  
premature	  delivery,	  and	  early	  neonatal	  deaths.	  In	  Ethiopia	  they	  found	  albuminuria	  in	  11.5%	  
and	  abnormal	  diastolic	  blood	  pressure	  in	  12.2%,	  where	  2.9%	  (all	  of	  whom	  lived	  in	  urban	  
areas)	  and	  9.2%	  were	  classified	  as	  pre-­‐eclamptic	  and	  gestational	  hypertensive,	  respectively.	  
52.3%	  were	  not	  receiving	  antenatal	  care	  services	  [4]. A	  World	  Health	  Organization	  analysis	  of	  
causes	  of	  maternal	  death	  states	  that	  9,1%	  of	  maternal	  deaths	  in	  Africa	  are	  due	  to	  
hypertensive	  disorders	  [5].	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Figure	  1-­‐	  Causes	  of	  maternal	  deaths	  worldwide	  
In	  many	  low-­‐income	  countries,	  complications	  of	  pregnancy	  and	  childbirth	  are	  the	  leading	  
cause	  of	  death	  amongst	  women	  of	  reproductive	  years.	  Most	  maternal	  deaths	  are	  potentially	  
avoidable.	  They	  could	  be	  prevented	  by	  access	  to	  emergency	  obstetric	  care	  and	  skilled	  
attendance	  during	  pregnancy,	  childbirth	  and	  at	  immediate	  postnatal	  period.	  	  	  Hypertension	  
in	  pregnancy	  is	  among	  the	  few	  direct	  causes	  of	  maternal	  deaths	  that	  can	  be	  detected	  and	  
prevented	  during	  pregnancy.	  Studies	  have	  shown	  that,	  antenatal	  screening	  for	  hypertension	  
and	  proteinuria	  followed	  by	  close	  monitoring	  and	  treatment	  of	  pre-­‐eclampsia	  reduced	  
eclampsia	  related	  maternal	  mortality	  in	  by	  48-­‐68%	  [6,7].	  Therefore	  availability	  of	  magnesium	  
sulphate	  for	  treatment	  of	  pre-­‐eclampsia	  and	  eclampsia	  at	  health	  facilities	  and	  availability	  of	  
skilled	  health	  personnel	  with	  knowledge	  and	  skills	  in	  managing	  hypertension	  is	  vital	  for	  
prevention	  of	  hypertensive	  related	  deaths	  [8]. 
Many	  studies	  have	  evaluated	  evidence-­‐based	  interventions	  to	  reduce	  hypertension	  related	  
maternal	  deaths.	  Systematic	  screening	  of	  pregnant	  women	  during	  antenatal	  period	  for	  
hypertension,	  routine	  calcium	  supplementation	  for	  women	  at	  high	  risk	  of	  pre-­‐eclampsia,	  
treatment	  of	  pre	  and	  eclampsia	  with	  magnesium	  sulphate	  and	  early	  delivery	  if	  women	  with	  
pre-­‐eclampsia	  and	  eclampsia	  have	  all	  been	  extensively	  studied	  and	  have	  a	  potential	  to	  
reduce	  the	  risk	  of	  maternal	  deaths	  by	  84%	  [9,10,11].	  These	  interventions	  are	  however	  required	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to	  be	  given	  by	  skilled	  health	  providers.	  Limited	  literatures	  exist	  on	  how	  knowledgeable	  the	  
health	  care	  professionals	  are	  regarding	  to	  hypertension	  in	  pregnancy	  and	  its	  management	  in	  
developing	  countries	  where	  maternal	  deaths	  are	  high.	  	  	  	  
Many	  of	  the	  root	  causes	  are	  related	  to	  poverty	  and	  inequity	  of	  opportunity	  for	  women.	  In	  
low-­‐income	  countries,	  primarily	  in	  Africa	  and	  Asia,	  maternal	  mortality	  is	  still	  100-­‐200	  times	  
higher	  than	  it	  is	  in	  Europe	  and	  North	  America.	  There	  is	  no	  other	  public	  health	  statistic	  for	  
which	  the	  disparity	  between	  rich	  and	  poor	  countries	  is	  so	  wide	  [12].	  Such	  a	  discrepancy	  poses	  
a	  huge	  challenge	  to	  meeting	  the	  fifth	  Millennium	  Development	  Goal	  to	  reduce	  maternal	  
mortality	  by	  75%	  between	  1990	  and	  2015	  [13].	  In	  high-­‐mortality	  countries	  today,	  especially	  
for	  the	  poorest	  populations,	  health	  systems	  are	  frequently	  the	  source	  of	  catastrophic	  costs,	  
and	  deeping	  social	  exclusion.	  The	  picture	  for	  maternal	  mortality,	  while	  not	  yet	  benefiting	  
from	  as	  carefully	  calibrated	  an	  epidemiological	  mapping,	  was	  similarly	  clear:	  skilled	  care	  in	  
delivery	  and	  particularly	  access	  to	  emergency	  obstetric	  care	  in	  the	  case	  of	  complications	  
would	  greatly	  reduce	  maternal	  deaths	  by	  about	  75%	  according	  to	  World	  Bank	  estimates	  [14].	  
	  
1.1.2	  Pathology	  and	  complications	  
Pre-­‐eclampsia	  is	  a	  disorder	  of	  placental	  development	  thought	  to	  arise	  from	  a	  mismatch	  
between	  uteroplacental	  supply	  and	  fetal	  demands.	  The	  resulting	  placental	  release	  of	  biologic	  
factors	  causes	  systemic	  maternal	  endothelial	  cell	  dysfunction	  and	  end-­‐organ	  complications	  
that	  include	  severe	  hypertension,	  eclampsia,	  pulmonary	  edema,	  and	  HELLP	  syndrome	  
(hemolysis,	  elevated	  liver	  enzymes	  and	  low	  platelet	  count)	  [14].	  
Hypertensive	  diseases	  of	  pregnancy	  are	  characterized	  by	  multi	  system	  involvement,	  with	  
complications	  commonly	  occurring	  in	  the	  renal,	  hepatic,	  cardiovascular,	  hematologic	  and	  
central	  nervous	  systems.	  Early	  detection	  and	  multidisciplinary	  treatment	  is	  important,	  
together	  with	  obstetric	  intervention	  [15].	  	  
Placental	  abruption,	  preterm	  delivery,	  perinatal	  death,	  small	  for	  gestational	  age	  infants,	  and	  
neonatal	  respiratory	  distress	  syndrome	  have	  all	  been	  reported	  to	  occur	  more	  commonly	  
among	  women	  who	  develop	  severe	  gestational	  hypertension	  without	  proteinuria	  than	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among	  women	  who	  develop	  proteinuria	  without	  severe	  hypertension	  [2]	  
	  
1.1.3	  Classification	  of	  high	  blood	  pressure	  in	  pregnancy	  [1]	  
•  Chronic	  hypertension:	  Hypertension	  prior	  to	  conception,	  or	  diagnosed	  before	  20th	  
week	  of	  gestation	  that	  does	  not	  resolve	  postpartum.	  Called	  	  ”essential	  hypertension”	  
if	  there	  is	  no	  underlying	  cause,	  and	  	  ”secondary	  hypertension”	  if	  there	  is	  an	  
underlying	  cause.	  	  
•  Preeclampsia-­‐eclampsia:	  Preeclampsia	  is	  a	  systemic	  disease	  with	  hypertension	  
accompanied	  by	  proteinuria	  after	  20th	  week	  of	  gestation.	  Eclampsia	  defined	  as	  the	  
occurence	  of	  seizures	  in	  preeclampsia.	  
•  Preeclampsia	  superimposed	  on	  chronic	  hypertension:	  	  Describes	  hypertensive	  
women	  who	  develop	  new	  onset	  proteinuria,	  proteinuria	  before	  20th	  week	  of	  
gestation,	  or	  sudden	  uncontrolled	  hypertension	  
•  Gestational	  hypertension:	  High	  blood	  pressure	  after	  mid-­‐pregnancy	  without	  
proteinuria:	  this	  diagnosis	  is	  used	  only	  during	  pregnancy	  with	  definitive	  diagnosis	  
made	  post	  partum.	  [15,	  16]	  
1.1.4	  Diagnosis	  
Hypertension	  is	  arbitrarily	  defined	  as	  a	  sustained	  blood	  pressure	  of	  ≥140/90	  mm	  Hg,	  
regardless	  of	  gender	  or	  pregnancy	  status	  [17].	  There	  is	  consensus	  that	  sustained	  severe	  
hypertension	  should	  be	  treated.	  Severe	  hypertension	  is	  defined	  as	  a	  systolic	  blood	  pressure	  
≥160	  to	  170	  mm	  Hg	  and/or	  diastolic	  blood	  pressure	  ≥110	  mm	  Hg	  [2].	  No	  conclusions	  can	  be	  
made	  about	  the	  relative	  maternal	  or	  perinatal	  benefits/risks	  of	  antihypertensive	  therapy	  for	  
mild-­‐to-­‐moderate	  pregnancy	  hypertension,	  regardless	  types	  [17].	  Blood	  pressure	  
measurement	  and	  urine	  analyses	  are	  the	  mainstay	  of	  the	  diagnosis	  and	  monitoring	  of	  
hypertensive	  disease	  during	  pregnancy	  [15].	  Early	  detection	  of	  hypertension	  requires	  
accurate	  measurement	  of	  the	  woman's	  blood	  pressure.	  A	  professional	  nurse	  should	  carefully	  
do	  this	  task,	  which	  too	  often	  is	  left	  to	  unlicensed	  assistant	  personnel.	  Another	  important	  
step	  is	  to	  differentiate	  between	  hypertension	  that	  was	  present	  prior	  to	  pregnancy	  and	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hypertension	  associated	  with	  the	  pregnancy-­‐specific	  disease	  of	  preeclampsia	  [16].	  In	  low-­‐
income	  countries,	  the	  contribution	  of	  chronic	  hypertension	  to	  hypertensive	  disease	  during	  
pregnancy	  remains	  speculative	  because	  pre-­‐pregnant	  blood	  pressure	  is	  not	  widely	  available	  
[15].	  
Twenty-­‐four-­‐hour	  ambulatory	  blood	  pressure	  monitoring	  can	  show	  alteration	  in	  the	  normal	  
pattern	  of	  blood	  pressure	  variation,	  a	  feature	  particularly	  relevant	  in	  preeclampsia,	  as	  these	  
women	  showed	  an	  impairment	  in	  the	  night-­‐time	  fall	  on	  blood	  pressure	  present	  in	  both	  
normotensive	  and	  gestational	  hypertensive	  patients.	  But	  there	  is	  no	  randomized	  controlled	  
trial	  evidence	  to	  support	  the	  use	  of	  ambulatory	  blood	  pressure	  monitoring	  during	  pregnancy	  
[18].	  
1.1.5	  Treatment	  and	  management	  
All	  antihypertensive	  agents	  have	  been	  shown	  or	  should	  be	  assumed	  to	  cross	  the	  placenta	  
and	  reach	  the	  fetal	  circulation.	  ACE	  inhibitors	  and	  angiotensin	  receptor	  antagonists	  when	  
taken	  later	  in	  pregnancy	  are	  associated	  with	  a	  characteristic	  fetopathy	  and	  are	  the	  only	  
antihypertensive	  agents	  contraindicated	  in	  pregnancy.	  Antenolol	  is	  not	  recommended	  for	  
use	  in	  pregnancy,	  given	  particular	  concerns	  about	  its	  potential	  to	  increase	  the	  risk	  of	  a	  small	  
for	  gestational	  age	  infant	  [17].	  	  
WHO	  states	  that	  magnesuim	  sulphate	  is	  the	  drug	  of	  choice	  for	  both	  prevention	  and	  
treatment	  for	  eclampsi	  [19].	  	  
Maternal	  deaths	  from	  hypertensive	  disorders	  in	  pregnancy	  can	  probably	  be	  reduced	  
markedly	  by	  [1]:	  	  
1. Promoting	  antenatal	  care	  and	  instituting	  a	  recall	  system	  for	  defaulters	  
2. Instituting	  regional	  centers	  and	  regional	  obstetricians	  to	  provide	  advice	  on,	  or	  care	  
for,	  women	  with	  severe	  preeclampsia	  
3. Educating	  health	  professionals	  through	  continuing	  professional	  education	  and	  the	  
use	  of	  clinical	  guidelines	  of	  management.	  
4. Informing	  the	  general	  public	  on	  complications	  associated	  with	  the	  
preeclampsia/eclampsia	  syndrome.	  
Elisabeth	  Berg	  Lohre	  and	  Sara	  Liljevik,	  Medical	  students,	  University	  of	  Oslo	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   10	  
	  
1.1.6	  Manangment	  of	  pregnancy-­‐induced	  hypertension,	  pre-­‐eclampsia,	  and	  
eclampsia	  
-­‐	  WHO`s	  guidelines	  [19]	  
Pregnancy-­‐induced	  hypertension:	  	  	  
Diastolic	  blood	  pressure	  is	  90-­‐100mmHg	  and	  there	  is	  no	  proteinuria.	  The	  woman	  is	  usally	  
mananged	  as	  an	  outpatient.	  
• Weekly	  follow	  up	  at	  home	  or	  local	  clinic:	  Monitor	  blood	  pressure,	  urine	  (for	  
proteinuria)	  and	  fetal	  condition	  (growth,	  movement,	  heart	  rate)	  
• Check	  if	  the	  woman	  has	  severe	  headache,	  visual	  disturbances	  or	  abdominal	  
pain.	  
• Counsel	  the	  woman	  and	  her	  family	  about	  the	  danger	  signals	  of	  severe	  
preeclampsia,	  ensuring	  that	  they	  know	  the	  importance	  of	  obtaining	  
immediate	  medical	  help	  if	  any	  of	  these	  signs	  develop.	  
• If	  the	  blood	  pressure	  decreases	  to	  normal	  levels	  and	  there	  are	  no	  other	  
complications,	  the	  condition	  has	  stabilized	  and	  the	  woman	  should	  be	  allowed	  
to	  proceed	  with	  normal	  labour	  and	  childbirth.	  If	  the	  blood	  pressure	  rises,	  
however,	  and/or	  proteinuria	  develops,	  or	  there	  is	  significant	  fetal	  growth	  
restriction	  or	  fetal	  compromise,	  treat	  as	  for	  preeclampsia	  (see	  below)	  
	  
Mild	  preeclampsia:	  	  
Diastolic	  blood	  pressure	  is	  between	  90-­‐110	  mmHg	  and	  there	  is	  up	  to	  2+	  of	  protein	  in	  the	  
urine.	  Refer	  the	  woman	  to	  a	  hospital.	  
	  
	  
If	  gestation	  is	  less	  than	  37	  weeks:	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•  If	  signs	  remain	  unchanged	  or	  normalize,	  follow	  up	  twice	  weekly	  as	  an	  
outpatient.	  Monitor	  blood	  pressure,	  urine	  (for	  proteinuria),	  reflexes	  and	  fetal	  
condition	  (growth,	  movement,	  fetal	  heart).	  	  Counsel	  the	  woman	  and	  her	  
family	  about	  danger	  signs	  of	  severe	  preeclampsia	  and	  eclampsia.	  Encourage	  
additional	  periods	  of	  rest,	  and	  to	  eat	  a	  normal	  diet.	  Do	  not	  give	  diuretics,	  
anticonvulsants,	  antihypertensives,	  sedatives	  or	  tranquillizers.	  
•  If	  there	  are	  signs	  of	  growth	  restriction,	  consider	  an	  early	  delivery;	  if	  not	  
continue	  hospitalization	  until	  term.	  
•  If	  urine	  protein	  level	  increases,	  manage	  as	  severe	  preeclampsia	  (see	  below).	  
	  	  If	  gestation	  is	  more	  than	  37	  weeks:	  
• If	  there	  are	  signs	  of	  fetal	  compromise,	  assess	  the	  cervix	  and	  expect	  delivery.	  If	  
the	  cervix	  is	  favorable	  (soft,	  thin,	  partly	  dilated),	  rupture	  membranes	  with	  an	  
amniotic	  hook	  or	  a	  Kocher	  clamp	  and	  induce	  labour	  using	  oxytocin	  or	  
prostaglandins.	  If	  the	  cervix	  is	  unfavorable	  (thick,	  firm	  and	  closed),	  ripen	  the	  
cervix	  using	  prostaglandins	  of	  a	  Foley	  catheter	  or	  deliver	  the	  woman	  by	  
caesarean	  section.	  
	  
Severe	  preeclampsia	  and	  eclampsia:	  
In	  severe	  preeclampsia	  delivery	  should	  take	  place	  within	  24	  hours	  of	  the	  onset	  of	  the	  
symptoms;	  in	  eclampsia	  delivery	  should	  take	  place	  earlier,	  within	  12	  hours	  of	  the	  onset	  of	  
convulsions.	  
The	  management	  of	  eclampsia	  involves	  six	  stages:	  
1. Making	  sure	  the	  airways	  are	  clear	  and	  the	  woman	  can	  breathe.	  
2. Controlling	  the	  fits	  (drug	  of	  choice	  is	  magnesium	  sulphate).	  
3. Controlling	  the	  blood	  pressure	  (drug	  of	  choice	  is	  hydralazine).	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4. General	  care	  and	  monitoring,	  including	  controlling	  fluid	  balance.	  
5. Delivering	  the	  baby.	  
6. Monitoring	  carefully	  to	  prevent	  further	  fits	  and	  identify	  complications.	  
	  
1.1.7	  Literature	  review	  
A	  meta-­‐analysis	  from	  British	  Medical	  Journal	  states	  that	  mean	  arterial	  pressure	  is	  a	  better	  
predictor	  for	  preeclampsia	  than	  systolic	  blood	  pressure,	  diastolic	  blood	  pressure,	  or	  
increased	  blood	  pressure.	  Blood	  pressure	  measurements	  at	  the	  first	  antenatal	  visit	  for	  
healthy	  normotensive	  women	  in	  the	  first	  and	  second	  trimester	  do	  not	  help	  predict	  
preeclampsia	  [20]. 
Another	  meta-­‐analysis	  from	  Elsevier	  revealed	  that	  the	  only	  interventions	  shown	  to	  prevent	  
preeclampsia	  are	  antiplatelet	  agents,	  primarily	  low	  dose	  aspirin,	  and	  calcium	  
supplementation.	  Magnesium	  sulfate	  can	  prevent	  and	  control	  eclamptic	  seizures.	  For	  
preeclampsia,	  it	  more	  than	  halves	  the	  risk	  for	  eclampsia	  (number	  needed	  to	  treat	  100,	  95%	  
confidence	  interval	  50-­‐100)	  and	  probably	  reduces	  the	  risk	  for	  maternal	  death [1]. 
A	  study	  conducted	  in	  Ethiopia	  regarding	  high-­‐risk	  pregnancies	  states	  the	  need	  for	  an	  
improved	  social	  environment,	  appropriate	  training	  of	  community	  health	  workers,	  and	  
strengthening	  maternity	  services,	  including	  family	  planning	  services.	  It	  also	  revealed	  that	  
85%	  of	  all	  the	  pregnancies	  in	  this	  specific	  study	  had	  at	  least	  one	  risk	  factor	  and	  therefor	  was	  
considered	  a	  high-­‐risk	  pregnancy	  [4].	  	  
A	  review	  from	  Expert	  review	  states	  that	  most	  antihypertensive	  agents	  are	  safe,	  but	  
angiotensin-­‐converting	  enzyme	  inhibitors	  are	  teratogenic	  and	  fetotoxic.	  The	  first-­‐line	  
antihypertensive	  treatment	  that	  should	  be	  administered	  during	  pregnancy	  if	  chronic	  
hypertension	  exists	  is	  methyldopa.	  The	  first-­‐line	  antihypertensive	  treatment	  that	  should	  be	  
administered	  during	  pregnancy	  if	  preeclampsia	  exists	  is	  labetalol.	  Hypertensive	  disorders	  of	  
pregnancy	  increase	  risk	  of	  cardiovascular	  disease	  in	  later	  life	  [21]. 
An	  article	  from	  Current	  Hypertension	  Reports	  states	  that	  there	  is	  consensus	  that	  blood	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pressure	  should	  be	  treated	  when	  it	  is	  sustained	  at	  ≥160	  to	  170	  mm	  Hg	  systolic	  and/or	  ≥110	  
mm	  Hg	  diastolic	  because	  of	  the	  short	  term	  risk	  of	  maternal	  vascular	  damage,	  particularly	  
stroke.	  There	  is	  no	  consensus	  regarding	  management	  of	  non-­‐severe	  hypertension	  [2].	  
	  
An	  intervention	  review	  from	  The	  Cochrane	  Collaboration	  says	  that	  there	  is	  no	  randomized	  
controlledtrial	  evidence	  to	  support	  the	  use	  of	  ambulatory	  blood	  pressure	  monitoring	  during	  
pregnancy	  [18]. 
An	  article	  published	  in	  International	  Journal	  of	  Gynecology	  and	  Obstetrics,	  revealed	  that	  in	  
low-­‐income	  countries,	  challenges	  associated	  with	  hypertensive	  disease	  during	  pregnancy	  
relate	  to	  the	  lack	  of	  cheap	  and	  reliable	  tools	  for	  diagnosis,	  management,	  and	  prevention.	  
Although	  there	  is	  a	  clinically	  proven,	  highly	  effective,	  cheap,	  and	  safe	  intervention	  for	  
preeclampsia/eclampsia,	  there	  are	  barriers	  to	  its	  large-­‐scale	  implementation	  for	  reducing	  
the	  impact	  of	  this	  preventable	  contributor	  to	  maternal	  morbidity	  and	  mortality	  [15]. 
A	  review	  from	  European	  Journal	  of	  obstetrics,	  gynecology	  and	  reproductive	  biology	  looked	  
at	  different	  methods	  to	  reduce	  maternal	  and	  perinatal	  mortality	  in	  rural	  and	  peri-­‐rural	  
settings.	  One	  of	  the	  settings	  was	  Nigeria.	  In	  Nigeria	  professional	  midwives	  were	  trained	  in	  
interpersonal	  communication	  and	  lifesaving	  obstetric	  skills,	  while	  referral	  hospitals	  were	  
refurbished	  and	  equipped.	  That	  made	  maternal	  deaths	  decline	  among	  all	  causes	  [22]. 
	  
	  
1.2.0	  Background	  information	  about	  Tanzania	  
1.2.1	  Location	  and	  population:	  
Tanzania	  is	  located	  in	  Eastern	  Africa	  and	  has	  frontier	  to	  Kenya	  and	  Uganda	  in	  the	  north,	  
Rwanda,	  Burundi	  and	  Democratic	  Republic	  of	  Congo	  in	  the	  west	  and	  Zambia,	  Malawi	  and	  
Mozambique	  in	  the	  south.	  In	  the	  east	  lies	  the	  Indian	  Ocean	  [23].	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The	  population	  is	  43,739,000	  people	  [24].	  
1.2.2	  Maternal	  and	  newborn	  health	  situation	  (indicators):	  
The	  maternal	  mortality	  ratio	  in	  Tanzania	  from	  2008	  is	  according	  to	  WHO	  790	  per	  100	  000	  live	  
births	  [25].	  The	  WHO	  countdown	  report	  from	  2010	  states	  that	  76	  percent	  of	  women	  in	  
Tanzania	  aged	  15-­‐49	  years	  attended	  antenatal	  care	  with	  a	  skilled	  health	  provider	  at	  least	  
once	  during	  pregnancy.	  Around	  43	  percent	  delivered	  with	  a	  skilled	  health	  professional	  and	  
51	  percent	  received	  postnatal	  care	  after	  delivery.	  The	  infant	  mortality	  rate	  was	  74	  per	  1000	  
live	  births	  [26,27].	  
1.3.0	  Statement	  of	  problem	  
Follow-­‐up	  and	  treatment	  of	  pregnant	  hypertensive	  women	  are	  important	  because	  it	  can	  
prevent	  preeclampsia	  and	  serious	  end-­‐organ	  damages.	  The	  mortality	  and	  morbidity	  for	  the	  
women	  and	  their	  children	  associated	  with	  preeclampsia	  and	  its	  complications	  are	  a	  major	  
burden,	  particularly	  in	  low-­‐and	  middle-­‐income	  countries	  [12].	  
Many	  women	  (70%)	  are	  attending	  for	  antenatal	  care	  in	  developing	  countries.	  The	  incidence	  
of	  hypertension	  in	  pregnancy	  and	  pre-­‐eclampsia	  is	  similar	  in	  developed	  and	  developing	  
countries	  [28].	  However	  deaths	  due	  to	  eclampsia	  are	  few	  in	  developed	  compared	  to	  
developing	  countries	  showing	  there	  is	  a	  missed	  opportunity	  to	  prevent	  hypertensive	  related	  
maternal	  deaths	  in	  these	  countries	  due	  to	  substandard	  quality	  of	  care	  given.	  The	  reasons	  for	  
substandard	  care	  on	  hypertension	  in	  pregnancy	  differ	  between	  settings	  in	  developing	  
countries	  driving	  the	  need	  to	  have	  local	  data	  on	  what	  are	  the	  main	  problems	  from	  health	  
system	  side;	  is	  it	  equipment	  and	  supplies,	  drugs,	  low	  knowledge	  and	  skills	  among	  providers	  
or	  poor	  referral	  system.	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There	  is	  a	  need	  for	  cheap	  and	  reliable	  tools	  with	  which	  to	  address	  the	  diagnostic,	  preventive,	  
and	  management	  challenges	  associated	  with	  hypertensive	  disease	  during	  pregnancy	  in	  low-­‐
income	  countries.	  It	  is	  recommended	  that	  countries	  incorporate	  magnesium	  sulphate	  
protocols	  into	  their	  national	  health	  and/or	  policies	  [15].	  As	  stated	  by	  Langer	  et	  al,	  “	  Scaling	  up	  
the	  use	  of	  magnesium	  sulfate	  for	  treatment	  of	  eclampsia	  and	  severe	  preeclampsia	  will	  
significantly	  advance	  the	  safe	  motherhood	  agenda	  and	  contribute	  to	  reaching	  the	  
Millennium	  Development	  Goals	  by	  2015”	  [12].	  
1.4.0	  Justification	  of	  study	  
We	  intend	  to	  look	  at	  the	  WHO's	  guidelines	  regarding	  hypertension	  in	  pregnancy	  and	  see	  if	  
they	  are	  followed	  by	  health	  providers	  in	  a	  developing	  country	  like	  Tanzania.	  We	  chose	  
WHO’s	  guidelines	  because	  it	  will	  be	  easier	  to	  compare	  our	  findings	  to	  other	  researchers,	  and	  
because	  WHO’s	  guidelines	  are	  supposed	  to	  be	  universal.	  	  This	  is	  an	  important	  study	  because	  
it	  will	  give	  baseline	  information	  about	  the	  level	  of	  knowledge	  and	  practice	  of	  health	  
providers	  on	  hypertension	  in	  pregnancy.	  The	  information	  will	  be	  vital	  for	  health	  managers	  of	  
maternal	  and	  newborn	  programs	  because	  it	  will	  show	  where	  resources	  and	  efforts	  should	  be	  
directed	  in	  order	  to	  improve	  outcomes	  of	  pregnancies	  with	  hypertension	  in	  developing	  
countries.	  	  
1.5.0	  Research	  question	   	  
What	  is	  the	  level	  of	  knowledge	  of	  health	  providers	  regarding	  hypertension	  in	  pregnancy	  and	  
do	  	  the	  health	  personnel	  in	  Moshi,	  Tanzania,	  follow	  the	  WHO's	  guidelines	  for	  management	  
and	  treatment	  of	  hypertensive,	  pregnant	  women?	  
Elisabeth	  Berg	  Lohre	  and	  Sara	  Liljevik,	  Medical	  students,	  University	  of	  Oslo	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   16	  
2 CHAPTER TWO 
2.1.0	  Objectives	  
2.1.1	  Broad	  objective	  	  
To	  assess	  level	  of	  knowledge	  and	  management	  practices	  of	  hypertension	  in	  pregnancy	  
among	  HCW	  in	  Moshi	  urban	  district,	  Northern	  Tanzania.	  
2.1.2	  Specific	  objectives	  	  
• To	  assess	  level	  of	  knowledge	  regarding	  HT	  in	  pregnancies	  among	  HCW	  in	  Moshi	  
urban	  district.	  
• To	  describe	  level	  of	  knowledge	  regarding	  WHO	  guidelines	  for	  HT	  management	  among	  
HCW	  in	  Moshi	  urban	  district.	  
• 	  To	  describe	  the	  practice	  of	  HCW	  regarding	  management	  of	  HT	  during	  pregnancy.	  
• 	  To	  assess	  if	  health	  facilities	  have	  adequate	  supplies,	  drugs	  and	  equipment	  for	  
management	  of	  HT	  during	  pregnancy	  and	  delivery	  period.	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3 CHAPTER  THREE 
3.1.0	  Methodology	  	  
3.1.1	  Study	  design	  	  
The	  study	  was	  a	  cross-­‐sectional	  facility	  based	  study	  	  
3.1.2	  Study	  area	  	  
The	  study	  was	  conducted	  at	  2	  primary	  health	  care	  clinics	  (PHC)	  with	  antenatal	  and	  delivery	  
services	  in	  Moshi	  municipality,	  in	  northern	  Tanzania.	  The	  clinics	  included	  in	  the	  study	  were	  
Majengo	  and	  Pasua	  clinics	  situated	  in	  Moshi	  urban	  district,	  one	  of	  the	  districts	  in	  Kilimanjaro	  
region.	  Pasua	  clinic	  have	  513	  deliveries	  per	  year	  and	  2748	  women	  attending	  ANC	  per	  year.	  
For	  Majengo	  we	  don't	  have	  these	  numbers.	  But	  we	  can	  assume	  they	  are	  about	  the	  same.	  	  
Kilimanjaro	  is	  one	  of	  the	  26	  regions	  in	  Tanzania.	  The	  capital	  of	  the	  region	  is	  Moshi.	  
Kilimanjaro	  Region	  is	  bordered	  to	  the	  North	  and	  East	  by	  Kenya,	  to	  the	  South	  by	  the	  Tanga	  
Region,	  to	  the	  Southwest	  by	  the	  Manyara	  Region,	  and	  to	  the	  West	  by	  the	  Arusha	  Region.	  
With	  an	  area	  of	  13,210km²,	  Kilimanjaro	  Region	  is	  the	  smallest	  region	  among	  Tanzania	  
Mainland’s	  21	  regions.	  	  According	  to	  the	  2002	  Tanzania	  National	  Census,	  the	  population	  of	  
the	  Kilimanjaro	  Region	  was	  1,381,149,	  which	  are	  4%	  of	  the	  country's	  population	  of	  about	  
43,739,000	  people.	  	  
The	  Kilimanjaro	  Region	  is	  administratively	  divided	  into	  7	  districts:	  Rombo,	  Hai,	  Moshi	  Rural,	  
Moshi	  Urban,	  Mwanga,	  and	  Same.	  According	  to	  the	  2002	  Tanzania	  National	  Census,	  the	  
population	  of	  the	  Moshi	  Urban	  District	  is	  144,336.	  The	  Moshi	  Urban	  District	  is	  
administratively	  divided	  into	  15	  wards.	  The	  town	  is	  situated	  on	  the	  lower	  slopes	  of	  Mt	  
Kilimanjaro,	  a	  volcanic	  mountain	  that	  is	  the	  highest	  mountain	  in	  Africa.	  	  The	  town	  covers	  an	  
area	  of	  58km²	  and	  lies	  approximately	  3°18’s	  and	  37°20’E.	  It	  slopes	  from	  about	  950m	  above	  
sea	  level	  to	  the	  North	  to	  700m	  above	  sea	  level	  to	  the	  South.	  	  
	  Thanks	  to	  the	  government,	  local	  authorities,	  and	  Catholic	  and	  Lutheran	  missions,	  Moshi	  has	  
universal	  primary	  education	  and	  the	  highest	  literacy	  rate	  in	  the	  vicinity.	  
The	  main	  hospital	  in	  the	  area	  is	  the	  Kilimanjaro	  Christian	  Medical	  College.	  This	  huge	  complex	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serves	  a	  population	  of	  over	  11	  million	  individuals.	  The	  Good	  Samaritan	  Foundation	  opened	  it	  
in	  March	  1971.	  
The	  Kilimanjaro	  region	  has	  a	  good	  coverage	  of	  antenatal	  care.	  While	  the	  percentage	  of	  
women	  who	  gave	  live	  birth,	  and	  received	  ANC	  from	  a	  professional	  health	  worker	  for	  
Tanzania	  is	  94%,	  the	  percentage	  for	  Kilimanjaro	  region	  is	  99,2%	  [29].	  
Moshi	  urban	  has	  3	  government	  hospitals	  and	  2	  health	  centers	  with	  antenatal	  and	  delivery	  
services.	  	  
3.1.3	  Study	  population	  
Health	  personnel	  (Clinicians	  and	  nurses)	  working	  at	  antenatal,	  labour	  ward	  and	  postnatal	  
clinics	  at	  the	  two	  selected	  clinics.	  
3.1.4	  Inclusion	  	  
Clinicians,	  nurses	  or	  midwives	  working	  at	  antenatal,	  LW	  or	  postnatal	  clinic	  
3.1.5	  Exclusion	  
Unskilled	  health	  personnel,	  health	  personnel	  from	  other	  departments,	  students.	  
3.1.6	  Sample	  size	  and	  sampling	  method	  
Convenience	  sampling	  was	  used.	  All	  the	  HCW	  working	  at	  respective	  clinics	  during	  the	  study	  
period	  were	  invited	  to	  participate.	  
3.1.7	  Data	  collection	  method	  
Interviews	  were	  conducted	  with	  HCW	  to	  assess	  their	  level	  of	  knowledge	  and	  practices	  
regarding	  HT	  in	  pregnancy.	  Observation	  of	  daily	  practices	  regarding	  management	  practices	  
was	  done.	  
3.1.8	  Data	  collection	  tools	  
A	  structured	  questionnaire	  with	  closed	  and	  open-­‐ended	  questions	  was	  used	  to	  gather	  the	  
needed	  information	  from	  the	  health	  workers.	  The	  questionnaire	  was	  constructed	  in	  English.	  
This	  tool	  was	  used	  to	  determine	  the	  difference	  of	  knowledge	  amongst	  health	  workers	  
regarding	  education,	  experience	  and	  socioeconomic	  factors	  as	  age,	  sex	  and	  educational	  
region.	  	  In	  addition	  we	  had	  an	  observation	  checklist	  for	  practices	  and	  an	  inventory	  checklist	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for	  supplies,	  drugs	  and	  equipments.	  These	  documents	  are	  in	  the	  appendix.	  	  
3.2.0	  Variables	  	  	  
Dependent	  variables	  
• Level	  of	  knowledge	  on	  hypertension	  in	  pregnancy	  among	  health	  care	  providers	  




• Level	  of	  education	  
• Level	  of	  experience	  
• Attitude	  towards	  questionnaire	  
3.2.1	  Pre-­‐testing	  the	  questionnaire	  
Pre-­‐testing	   of	   structured	   questionnaire	  was	   carried	   out	   in	   Arendal	   and	  Oslo,	   two	   cities	   in	  
Norway,	  to	  find	  out	  areas	  of	  improvement	  before	  going	  to	  the	  clinics	  in	  Moshi,	  Tanzania.	  The	  
test	  was	  done	  to	  health	  care	  workers,	  who	  met	  the	  inclusion	  criteria	  of	  the	  study.	  Language	  
errors,	  flow	  and	  inconsistent	  of	  questions	  was	  corrected.	  	  	  	  
3.2.2	  Ethical	  consideration	  
Ethical	   clearance	   was	   sought	   from	   medical	   department	   of	   Moshi	   municipal	   council.	  
Introduction	   and	   aim	   of	   the	   study	   were	   clearly	   made	   to	   respondent	   before	   signing	   the	  
consent	  form	  (only	  if	  she/he	  agreed).	  The	  participant	  was	  asked	  to	  sign	  informed	  consent	  for	  
the	   study.	   The	   participants	   had	   the	   oppotunity	   to	   withdraw	   from	   the	   study	   at	   any	   time	  
without	  consequences.	  The	  study	  participants	  had	  the	  right	  to	  know	  what	  aim	  of	  the	  study	  
was.	  Confidentiality	  and	  respect	  of	  the	  personal	  privacy	  was	  maintained	  and	  collected	  data	  
will	  not	  be	  used	  in	  any	  other	  purposes.	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3.3.0	  Data	  processing	  and	  analysis	  
3.3.1	  Data	  processing	  
Each	  day	  at	   the	  clinics,	   the	  questionnaires	  were	  checked.	  Coding	  of	  open-­‐ended	  questions	  
and	  data	  entry	  was	  done	  on	  daily	  basis.	  Cleaning	  of	  data	  was	  done	  before	  the	  analysis.	  
3.3.1	  Data	  analysis	  
Descriptive	  statistics	  was	  used	  to	  summarize	  the	  data	  e.g.	  proportions,	  means	  and	  medians	  
with	  their	  measure	  of	  dispersion.	  Tables	  and	  charts	  were	  used	  to	  present	  summarized	  data.	  
Differences	  between	  groups	  were	  assessed	  using	  percentages.	  Analysis	  was	  done	  using	  SPSS	  
version	  14.	  	  
3.4.0	  Plan	  for	  utilization	  of	  results	  
The	   findings	   through	   this	   study	   was	   presented	   and	   submitted	   to	   the	   University	   of	   Oslo,	  
Norway.	  A	   copy	  will	  be	   sent	   to	  Kilimanjaro	  Christian	  Medical	  Center	   (KCMC),	  University	  of	  
Tumani.	  	  
4 CHAPTER FOUR 
4.1.0	  Results	  
In	  total,	  34	  HCW	  of	  	  42	  HCW	  (81%)	  from	  Majengo	  and	  Pasua	  were	  included	  in	  the	  study.	  27	  
were	  women	  and	  7	  were	  men	  and	  all	  of	  them	  were	  educated	  in	  Tanzania.	  The	  socio-­‐
demographic	  results	  are	  shown	  in	  the	  list	  below.	  In	  total	  there	  were	  16	  health	  care	  workers	  
in	  Majengo	  clinic	  and	  18	  at	  Pasua	  clinic	  respectively.	  Among	  the	  HCW	  in	  majengo	  8	  were	  
doctors	  	  and	  14	  nurses,	  while	  in	  Pasua	  it	  was	  8	  and	  14	  respectively.	  Out	  of	  22	  HCW	  in	  
Majengo	  13	  participated	  in	  the	  study	  (59%),	  while	  in	  pasua	  21	  (95%)	  of	  HCW	  participated.	  	  
4.1.1	  Socio-­‐demographic	  characteristics	  
In	  total,	  34	  HCW	  from	  Majengo	  and	  Pasua	  were	  included	  in	  the	  study,	  27	  were	  women	  and	  7	  
were	  men	  and	  all	  of	  them	  were	  educated	  in	  Tanzania.	  The	  socio-­‐demographic	  characteristics	  
of	  the	  participants	  are	  shown	  in	  table	  1	  below.	  The	  age	  ranged	  from	  24	  to	  60	  years,	  with	  a	  
mean	  age	  of	  38	  years	  old.	  Their	  mean	  experience	  was	  11	  years	  (	  0-­‐30	  years).	  The	  level	  of	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education	  is	  variable	  in	  Tanzania,	  where	  you	  would	  need	  a	  degree	  to	  be	  a	  doctor	  at	  a	  big	  
hospital,	  but	  suffice	  with	  a	  diploma	  on	  the	  countryside.	  The	  difference	  is	  the	  number	  of	  year	  
with	  education.	  	  	  
	  














































Table	  1-­‐	  Sociodemographic	  characteristics	  
	  
4.1.2	  Knowledge	  of	  HCW	  regarding	  different	  aspects	  of	  hypertension	  during	  
pregnancy	  
Knowledge	  on	  when	  to	  start	  ANC	  
Table	  2	  depicts	  HCWs	  knowledge	  on	  when	  the	  pregnant	  women	  should	  begin	  antenatal	  care.	  Fifty	  
percent	  (17	  HCW)	  stated	  that	  ANC	  should	  start	  in	  the	  1st	  trimester	  of	  the	  pregnancy.	  Only	  1	  HCW	  (	  
2,9%)	  would	  have	  it	  started	  in	  the	  3st	  trimester.	  Among	  those	  who	  wrote	  2st	  trimester	  it	  was	  equally	  
devided	  between	  doctors	  and	  midwifes,	  the	  same	  goes	  also	  for	  those	  who	  replied	  1st	  trimester.	  
There	  was	  little	  difference	  between	  the	  two	  clinics,	  Majengo	  and	  Pasua.	  
	   Frequency	   Percent	  
1.	  trimester	  
2.	  trimester	  













Table	  2-­‐	  At	  which	  trimester	  should	  ANC	  start?	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Knowledge	  about	  hypertension	  in	  pregnancy	  
Nearly	  sixty	  five	  percent	  (22)	  HCW	  knew	  	  that	  the	  blood	  pressure	  is	  high	  in	  pregnant	  woman	  
when	  is	  >	  	  140/90	  mm	  Hg.	  	  The	  rest	  had	  different	  answers	  and	  vary	  between	  130-­‐160	  mmHg	  
in	  systolic	  and	  80-­‐100	  mmHg	  in	  diastolic	  pressure.	  Most	  of	  the	  HCW	  at	  Majengo	  agreed	  on	  
140/90	  mmHg	  as	  a	  high	  blood	  pressure	  in	  pregnancy.	  At	  Pasua	  they	  are	  not	  that	  consistent,	  
and	  the	  answers	  differ	  highly.	  	  	  
	  
	  
Figure	  2-­‐	  When	  is	  BP	  to	  high?	  
Definition	  pre-­‐eclampsia	  
According	  to	  WHO’s	  definition	  pre-­‐eclampsia	  is	  defined	  as	  high	  BP	  during	  pregnancy	  (>	  
140/90)	  and	  presence	  of	  proteinuria.	  In	  total,	  56%	  (19)	  of	  the	  participants	  had	  adequate	  
knowledge	  of	  the	  definition	  of	  pre-­‐eclampsia.	  	  There	  wasn’t	  much	  difference	  if	  when	  
knowledge	  about	  preeclampsia	  was	  compared	  between	  the	  HCWs	  at	  Pasua	  and	  Majengo	  
clinics	  respectively.	  We	  define	  adequate	  knowledge	  as	  correct	  answer	  according	  to	  WHO’s	  
guidelines.	  
	   Frequency	   Percent	  
Adequate	  knowledge	   19	   55,9%	  
Inadequate	  knowledge	   15	   44,1%	  
Total	   34	   100%	  
Table	  3-­‐	  Definition	  preeclampsia	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4.1.3	  Knowledge	  about	  management	  of	  hypertension	  
Management	  and	  treatment	  hypertension	  during	  pregnancy	  
The	  WHO	  guidelines	  and	  the	  Tanzanian	  guidelines	  differ	  slightly	  in	  the	  case	  management	  of	  
hypertension	  during	  pregnancy.	  The	  WHO	  guidelines	  do	  	  not	  recommend	  	  treating	  HT	  in	  
pregnancy	  with	  antihypertensive	  drugs,	  but	  the	  Tanzanian	  guideline	  recommends	  treating	  
with	  hydralazine	  or	  methyldopa	  when	  the	  blood	  pressure	  exceeds	  140/90	  mmHg.	  	  We	  have	  
therefore	  chosen	  to	  see	  if	  the	  knowledge	  is	  adequate	  either	  to	  the	  WHO	  guidelines	  or	  the	  
Tanzanian	  guidelines.	  About	  eighteen	  percent	  of	  the	  HCW	  had	  adequate	  knowledge	  on	  how	  
to	  manage	  hypertension	  during	  pregnancy	  according	  to	  the	  guidelines	  recommended	  by	  the	  
WHO,	  and	  50%	  had	  adequate	  knowledge	  according	  to	  the	  Tanzanian	  guidelines.	  Most	  of	  the	  
doctors	  had	  adequate	  knowledge	  according	  Tanzanian	  guidelines,	  compared	  to	  WHO’s	  
guidelines,	  where	  none	  had	  adequate	  knowledge.	  
	  
How	  to	  manage	  and	  treat	  hypertension	  	  
	   Frequency	   Percent	  
According	  WHO	  
Adequate	  knowledge	  






















Table	  4-­‐	  How	  to	  manage	  and	  treat	  hypertension	  
 
Management	  and	  treatment	  pre-­‐eclampsia	  
The	  WHO	  guidelines	  and	  Tanzanian	  guidelines	  also	  differ	  in	  recommendations	  for	  treatment	  
of	  pre-­‐eclampsia.	  WHO	  doesn’t	  recommend	  treating	  pre-­‐eclampsia	  with	  drugs,	  but	  the	  
Tanzanian	  guidelines	  recommend	  treating	  with	  hydralazine	  or	  methyldopa.	  	  Only	  12%	  of	  the	  
HCWs	  had	  adequate	  knowledge	  regarding	  management	  of	  pre-­‐eclampsia	  according	  to	  the	  
Tanzanian	  guidelines	  and	  20,	  6	  percent	  according	  to	  WHO.	  Adequate	  knowledge	  is	  correct	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answer	  according	  to	  either	  Tanzanian	  or	  WHO’s	  guidelines.	  
	  
	   Frequency	   Percent	  
According	  WHO	  
Adequate	  knowledge	  






















Table	  5-­‐	  How	  to	  manage	  and	  treat	  pre-­‐eclampsia	  
	  
How	  to	  manage	  and	  treat	  eclampsia	  
There	  are	  no	  differences	  between	  the	  WHO	  guidelines	  and	  the	  Tanzanian	  guidelines	  
regarding	  management	  and	  treatment	  of	  eclampsia.	  	  Fifty	  nine	  percent	  of	  the	  HCW	  had	  
adequate	  knowledge	  regarding	  management	  of	  eclampsia	  according	  to	  WHO’s	  guidelines.	  	  
	  
	   Frequency	   Percent	  
Adequate	  knowledge	  








Table	  6-­‐	  How	  to	  manage	  and	  treat	  eclampsia	  
4.1.4	  Practice	  regarding	  management	  of	  hypertension	  based	  on	  observations	  during	  
antenatal	  care	  
Blood	  pressure	  
We	  observed	  99	  antenatal	  visits	  and	  66,7%	  of	  the	  pregnant	  women	  got	  their	  BP	  measured,	  	  92,6%	  of	  
the	  pregnant	  women	  at	  Majengo	  got	  their	  BP	  taken,	  compared	  to	  35,6%	  at	  Pasua.	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Table	  7-­‐	  Was	  the	  BP	  measured?	  
Weight	  	  
Almost	  every	  pregnant	  woman	  (96%)	  was	  weighed	  during	  the	  ANC	  visit.	  At	  Majengo	  it	  was	  100%,	  
while	  at	  Pasua	  the	  percentage	  of	  women	  weighed	  was	  91,	  2%.	  	  
	  
Urine	  check	  







4.1.5	  Inventory	  of	  necessary	  equipments	  &	  supplies	  for	  management	  of	  
hypertension	  at	  the	  clinics	  
Table	  9	  depicts	  an	  inventory	  of	  equipments	  and	  supplies	  at	  Majengo	  and	  Pasua	  clinics.	  Both	  Majengo	  
and	  Pasua	  had	  functional	  weighing	  machines	  and	  BP	  machines.	  While	  Majengo	  had	  both	  metyldopa	  
and	  hydralazine,	  Pasua	  had	  neither.	  None	  of	  the	  two	  clinics	  had	  any	  guidelines	  regarding	  HT	  in	  
pregnancy	  or	  pre-­‐eclampsia.	  
	  
	  
Elisabeth	  Berg	  Lohre	  and	  Sara	  Liljevik,	  Medical	  students,	  University	  of	  Oslo	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   26	  
Inventory	   Majengo	   Pasua	  
Weighing	  machine	   Present	   Present	  
BP	  machines	   2	   3	  
































Not	  present	   Not	  present	  










Elisabeth	  Berg	  Lohre	  and	  Sara	  Liljevik,	  Medical	  students,	  University	  of	  Oslo	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   27	  
4.1.6 Perceived	  challenges	  by	  HCWs	  
	  
The	  most	   frequent	   perceived	   challenge	  was	  medicine	   access	   (52,9%).	   	  Manpower	  was	   a	   challenge	  
perceived	  by	  41,2%	  of	  the	  HCW.	  While	  11,8%	  did	  not	  have	  any	  challenges	  regarding	  the	  treatment	  
and	  management	  of	  HT	  in	  pregnancy	  and	  pre-­‐eclampsia.	  
	  
Variable	   Number*	   Percent*	  
Medicine	  access	   18	  	   52,9%	  
Manpower	   14	  	   41,2%	  
Bad	  complience	   13	   38,2%	  
	  Cannot	  afford	  medications	   12	   35,3%	  
	  Patients	  rarly	  to	  control	   9	   26,5%	  
Unsure	  when	  to	  treat	  HT/pre-­‐eclampsia	   4	   11,8%	  
	  Unsure	  how	  to	  treat	  HT/pre-­‐eclampsia	   4	   11,8%	  
	  Do	  not	  find	  any	  challenges	   4	   11,8%	  
Lack	  of	  equipment	   2	   5,9%	  
*	  Multiple	  answers	  were	  possible	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Table	  9-­‐	  Perceived	  challenges	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5 CHAPTER FIVE 
5.1.0	  Discussion	  
5.1.1	  General	  
Knowledge	  of	  hypertension	  
Nearly	  65%	  of	  the	  health	  care	  workers	  in	  Moshi	  had	  adequate	  knowledge	  on	  definition	  of	  
high	  blood	  pressure	  during	  pregnancy.	  The	  level	  of	  variation	  is	  high	  and	  can	  be	  due	  to	  
uncertainty	  regarding	  definition	  of	  hypertension.	  At	  Majengo	  they	  were	  much	  more	  
consistent;	  this	  is	  not	  due	  to	  different	  percentage	  of	  doctors	  at	  the	  clinics,	  which	  were	  
approximately	  the	  same	  percentage.	  	  This	  is	  higher	  than	  what	  a	  survey	  in	  Taiwan	  found,	  
there	  adequate	  hypertension	  guidelines	  awareness	  was	  found	  in	  49,5%	  of	  the	  total	  sample.	  
Among	  the	  7	  dimensions	  of	  the	  Hypertension	  Management	  Questionnaire,	  the	  definition	  of	  
hypertension,	  methods	  for	  blood	  pressure	  measurements	  and	  impact	  of	  high	  blood	  pressure	  
on	  cardiovascular	  disease	  had	  the	  lowest	  rates	  of	  correct	  answers	  [30].	  	  
To	  detect	  high	  BP	  early	  it	  is	  important	  to	  start	  ANC	  in	  the	  first	  trimester.	  As	  many	  as	  44,	  1%	  
(15	  HCW)	  would	  start	  ANC	  at	  the	  second	  trimester.	  One	  HCW	  want	  to	  begin	  ANC	  in	  the	  third	  
trimester,	  but	  one	  person	  is	  not	  enough	  to	  be	  significant	  and	  is	  therefore	  not	  taken	  under	  
consideration.	  The	  definition	  of	  pre-­‐eclampsia	  according	  to	  WHO	  are	  BP	  ≥140/90	  mmHg,	  
proteinuria	  and	  edemas.	  To	  get	  adequate	  knowledge	  in	  our	  analysis,	  the	  HCW	  had	  to	  answer	  
at	  least	  high	  BP	  and	  proteinuria.	  	  We	  find	  higher	  knowledge	  among	  the	  doctors,	  compared	  to	  
midwives	  and	  nurses.	  This	  is	  corresponsive	  to	  what	  others	  researchers	  found,	  comparing	  the	  
level	  of	  knowledge	  of	  physicians	  and	  midwifes	  and	  nurses.	  The	  physicians	  scored	  an	  average	  
of	  55,2%	  correct	  answers	  compared	  to	  midwifes	  and	  nurses	  who	  scored	  on	  average	  less	  than	  
50%	  correct	  answers	  [31].	  	  
Knowledge	  of	  management	  and	  treatment	  
The	  Tanzanian	  guidelines	  are	  different	  from	  WHO.	  	  The	  WHO	  guidelines	  recommend	  
conservative	  treatment	  for	  hypertension	  and	  pre-­‐eclampsia,	  with	  bed	  rest	  and	  frequent	  
control	  of	  BP	  and	  urine	  for	  proteinuria.	  	  The	  Tanzanian	  guidelines	  on	  the	  other	  hand	  want	  to	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treat	  hypertension	  and	  pre-­‐eclampsia	  with	  antihypertensive	  like	  hydralazine	  or	  
methyldopamin.	  Only	  17,	  6%	  of	  the	  HCW	  replied	  correctly	  according	  to	  WHO’s	  guidelines	  on	  
how	  to	  treat	  and	  manage	  hypertension,	  while	  50%	  answered	  correct	  when	  looking	  at	  
Tanzanian	  guidelines	  instead.	  This	  shows	  that	  the	  HCW	  are	  more	  familiar	  with	  the	  Tanzanian	  
guidelines,	  but	  there	  is	  need	  for	  more	  information	  and	  education	  of	  HCW.	  	  When	  looking	  at	  
the	  level	  of	  knowledge	  regarding	  pre-­‐eclampsia	  we	  find	  the	  same	  pattern,	  only	  20,	  6%	  had	  
adequate	  knowledge	  according	  to	  WHO	  and	  11,	  8%	  to	  the	  Tanzanian	  guidelines.	  Again,	  we	  
find	  the	  need	  for	  more	  information	  and	  education.	  
The	  treatment	  of	  eclampsia	  is	  MgSO4	  or	  diazepam	  if	  MgSO4	  is	  not	  available,	  here	  the	  
Tanzanian	  guidelines	  and	  the	  WHO	  guidelines	  do	  not	  disagree.	  	  Still	  the	  level	  of	  knowledge	  is	  
not	  sufficient,	  58,8%	  answered	  correctly.	  Usually	  the	  clinics	  have	  an	  average	  of	  one	  
eclamptic	  woman	  per	  year.	  This	  could	  explain	  the	  lack	  of	  knowledge.	  They	  have	  513	  
deliveries	  at	  Pasua,	  and	  2748	  women	  attending	  ANC	  per	  year.	  	  
Observations	  
We	  observed	  99	  ANC,	  54	  at	  Majengo	  and	  45	  at	  Pasua.	  Almost	  all	  of	  the	  women	  got	  their	  BP	  
measured	  at	  Majengo,	  unlike	  Pasua	  where	  only	  35,	  6%	  was	  checked.	  This	  may	  indicate	  
better	  structure	  and	  routines	  during	  the	  consultations	  at	  Majengo.	  This	  goes	  well	  with	  the	  
impression	  we	  got	  during	  our	  observations.	  A	  survey	  conducted	  in	  Nigeria	  had	  a	  different	  
result;	  there	  all	  the	  women	  got	  their	  BP	  measured	  [32].	  The	  difference	  cannot	  be	  explained	  by	  
lack	  of	  equipment	  as	  Pasua	  had	  three	  BP	  machines,	  and	  Majengo	  only	  two.	  Some	  women	  did	  
not	  get	  their	  BP	  measured	  because	  the	  BP	  machine	  was	  being	  used	  by	  another	  HCW.	  This	  
explains	  some	  of	  the	  missing	  measurements	  on	  both	  clinics.	  	  When	  it	  comes	  to	  weight	  
measure,	  the	  clinics	  are	  more	  alike.	  Majengo	  measured	  the	  weight	  of	  every	  woman,	  which	  
again	  shows	  good	  routines.	  Pasua	  measured	  91,	  2%	  of	  the	  women,	  which	  also	  is	  good.	  It	  
seems	  like	  the	  HCW	  find	  it	  easier	  to	  measure	  weight	  than	  BP,	  this	  could	  be	  because	  of	  lack	  of	  
experience,	  knowledge	  or	  that	  the	  workload	  is	  too	  heavy,	  so	  they	  find	  it	  too	  time	  consuming	  
to	  measure	  both	  BP	  and	  weight.	  The	  mentioned	  reasons	  may	  also	  be	  the	  cause	  of	  why	  none	  
of	  the	  women	  was	  checked	  for	  proteinuria,	  even	  though	  they	  had	  appropriate	  equipment.	  In	  
the	  survey	  mentioned	  above,	  less	  than	  half	  of	  the	  pregnant	  women	  got	  their	  urine	  checked	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for	  protein	  [32].	  
Inventory	  
There	  is	  no	  big	  difference	  between	  the	  clinics;	  the	  main	  difference	  is	  regarding	  the	  drugs.	  
Pasua	  did	  not	  have	  any	  of	  the	  antihypertensive	  drugs	  recommended	  for	  pregnant	  women	  
when	  we	  visited	  the	  clinic,	  because	  they	  were	  out	  of	  stock.	  But	  they	  had	  medications	  for	  
eclampsia,	  which	  is	  important	  in	  case	  of	  an	  emergency.	  Similar	  results	  are	  found	  in	  a	  survey	  
from	  Nairobi,	  Nigeria	  where	  28%	  of	  the	  health	  facilities	  had	  magnesium	  sulphate,	  40%	  anti-­‐
hypertensives	  and	  68%	  parenteral	  anticonvulsants	  [33].	  None	  of	  the	  clinics	  have	  any	  
guidelines	  for	  eclampsia;	  this	  may	  be	  the	  cause	  of	  low	  level	  of	  knowledge.	  BP	  measurements	  
is	  an	  important	  tool	  in	  health	  clinics,	  and	  in	  relation	  to	  the	  size	  of	  the	  clinics,	  two	  and	  three	  
BP	  machines	  is	  not	  sufficient.	  
Perceived	  challenges	  
Medicine	  access	  seems	  to	  be	  the	  biggest	  challenge	  for	  the	  HCW	  and	  secondly	  manpower.	  
This	  is	  much	  related	  to	  economy	  and	  more	  money	  could	  solve	  these	  problems.	  Especially	  
manpower	  is	  very	  important	  when	  it	  comes	  to	  managing	  eclampsia;	  both	  clinics	  have	  only	  
one	  midwife	  and	  one	  nurse	  on	  duty	  during	  the	  night.	  There	  are	  only	  a	  few	  HCW	  who	  state	  
that	  they	  are	  unsure	  on	  how	  and	  when	  to	  treat	  hypertension	  and	  pre-­‐eclampsia,	  which	  do	  
not	  correlate	  with	  our	  results.	  A	  surprising	  finding	  is	  that	  35,	  3%	  report	  that	  many	  patients	  
cannot	  afford	  the	  medications,	  even	  though	  medications	  for	  pregnant	  women	  are	  supposed	  
to	  be	  free.	  	  
	  
5.1.2	  Limitation	  
This	  study	  was	  conducted	  in	  Moshi,	  urban	  district,	  and	  therefore	  these	  results	  can	  only	  give	  
information	  about	  the	  situation	  in	  an	  urban	  district.	  It	  must	  be	  taken	  into	  considerations	  that	  
Moshi	  is	  a	  small	  town	  in	  Tanzania	  and	  the	  results	  cannot	  be	  generalized	  to	  the	  rest	  of	  the	  
country.	  	  
We	  stayed	  at	  the	  clinics	  for	  only	  4	  weeks,	  2	  weeks	  at	  each	  clinic.	  To	  receive	  more	  
representative	  data,	  we	  should	  have	  stayed	  longer	  in	  order	  to	  give	  out	  more	  questionnaires	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and	  observations.	  We	  got	  34	  HCW	  to	  answer	  our	  questionnaires,	  this	  it	  not	  enough	  to	  make	  
any	  conclusions	  about	  the	  general	  level	  of	  knowledge.	  Some	  of	  the	  HCW	  did	  not	  want	  to	  
answer,	  other	  were	  away	  on	  vacation.	  But	  we	  got	  81%	  who	  replied,	  so	  it's	  satisfactory.	  	  
Some	  of	  the	  HCW	  had	  limited	  English	  skills,	  and	  this	  may	  have	  affected	  the	  results.	  But	  none	  
reported	  any	  difficulties	  understanding	  the	  questions.	  	  
We	  have	  subsequently	  realized	  that	  some	  of	  the	  questions	  may	  have	  been	  unclear	  and	  
therefore	  given	  wrong	  answers.	  This	  applies	  especially	  for	  question	  number	  9,	  we	  should	  
have	  specified	  that	  we	  wanted	  to	  know	  how	  to	  treat	  hypertension	  in	  pregnancy,	  not	  
hypertension	  in	  general.	  	  
To	  get	  the	  HCW	  to	  answer	  the	  questionnaire	  alone	  and	  without	  help	  was	  a	  challenge.	  Most	  
of	  them	  discussed	  the	  questions	  with	  each	  other	  before	  giving	  it	  back.	  	  
	  
5.2.0	  Conclusion	  
In	  our	  study	  we	  have	  been	  collecting	  information	  at	  two	  PHC’s	  in	  Moshi,	  Tanzania.	  Tanzania	  
is	  one	  of	  the	  world’s	  least	  developed	  countries	  and	  maternal	  mortality	  is	  still	  a	  major	  
problem.	  We	  have	  been	  giving	  out	  questionnaires	  to	  the	  HCWs	  to	  get	  an	  impression	  of	  the	  
level	  of	  knowledge.	  	  
Our	  objectives	  were:	  
• To	  assess	  the	  knowledge	  and	  management	  regarding	  hypertension	  in	  pregnancy	  
among	  HCW	  in	  Moshi,	  Tanzania.	  
• To	  describe	  the	  practice	  of	  HCW	  regarding	  management	  of	  hypertension	  during	  
pregnancy	  in	  Moshi	  urban	  district.	  
• To	  asses	  if	  PHC	  have	  adequate	  supplies,	  drugs	  and	  equipment	  for	  management	  and	  
hypertension	  during	  pregnancy	  and	  delivery	  periods	  in	  Moshi	  urban	  district.	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Our	  conclusion	  to	  the	  first	  objective	  is	  that	  the	  level	  of	  knowledge	  and	  management	  of	  
hypertension	  during	  pregnancy	  is	  too	  low.	  The	  percentage	  was	  65	  and	  21,	  knowledge	  and	  
management,	  respectively.	  	  
On	  the	  second	  objective	  we	  find	  that	  the	  practice	  is	  lacking	  routines	  and	  important	  
procedures	  are	  omitted.	  The	  probability	  to	  find	  critical	  symptoms	  is	  therefore	  reduced.	  	  
Regarding	  the	  third	  objective	  we	  found	  insufficiency	  of	  supplies	  compared	  to	  the	  number	  of	  
patients	  attending	  the	  clinic.	  
Our	  overall	  conclusion	  is	  general	  lack	  of	  knowledge	  and	  supplies,	  but	  to	  support	  this	  
conclusion	  there	  is	  need	  for	  more	  and	  thorough	  studies.	  Our	  results	  were	  interesting;	  
however	  the	  limitations	  are	  too	  many	  to	  land	  on	  a	  conclusion	  based	  on	  our	  analyses.	  	  	  	  	  	  	  
	  
5.3.0	  Recommendations	  
This	  study	  shows	  that	  the	  level	  of	  knowledge	  and	  routines	  at	  the	  PHCs	  is	  not	  sufficient.	  A	  
large	  country	  as	  Tanzania	  needs	  to	  have	  clear	  guidelines	  and	  structure,	  which	  we	  found	  a	  
lack	  of	  at	  the	  Pasua	  and	  Majengo	  clinics.	  Our	  recommendations	  after	  spending	  four	  weeks	  in	  
Moshi	  are	  as	  follows:	  	  
• Higher	  level	  of	  education	  and	  information	  among	  the	  HCW	  concerning	  hypertension	  
in	  pregnancy,	  and	  its	  complications	  and	  treatment.	  
• Awareness	  about	  the	  importance	  of	  urine	  analyses	  and	  BP	  measurement	  on	  regular	  
basis	  during	  the	  pregnancy.	  	  
• Noticeable	  and	  clear	  guidelines	  on	  hypertension	  in	  pregnancy	  at	  the	  clinic.	  
• More	  investment	  in	  equipment	  and	  medications.	  
• Better	  structure	  and	  efficiency	  at	  the	  clinics.	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7 CHAPTER SEVEN 
7.1.0	  Appendices	  
7.1.1	  Appendix	  1:	  Consent	  Form	  	  
My	  name	  is	  …………………………..On	  behalf	  of	  the	  University	  of	  Oslo,	  Norway.	  I	  am	  conducting	  a	  
study	   in	   Moshi	   urban	   District	   aiming	   at	   assessing	   the	   managenment	   and	   treatment	   og	  
hypertension	  in	  pregnancies.	  
	  
All	   health	   workers	   who	   will	   meet	   inclusion	   criteria	   during	   time	   of	   data	   collection	   will	   be	  
requested	  to	  participate	   	   	   in	   the	  study.	   If	   the	  request	   is	  positively	  agreed,	   then	  participant	  
will	  be	  asked	  questions	  through	  self	  reported	  adherence	  form.	  	  
You	  are	  kindly	  requested	  to	  participate	  in	  this	  study	  and	  give	  out	  your	  opinions	  and	  views.	  All	  
information	   will	   be	   kept	   secretly,	   no	   name	   is	   needed	   on	   my	   research	   paper.	   Your	  
participation	   is	   vital;	   however	   your	  participation	   is	   voluntarily.	   You	  are	   free	   to	  participate,	  
refuse	   or	   withdraw	   at	   any	   time	   even	   without	   any	   effects.	   However	   your	   participation	   is	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highly	  demanded	  and	  will	  be	  appreciated.	  	  
Therefore,	  I	  have	  read	  and	  understand	  the	  importance	  of	  this	  study.	  
	  
	  
Respondent	  signature	   	   	   	   	  	  	  	  Interviewer	  signature	   	  
……………………..	  	  	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  ………………………..	  




7.1.2	  Appendix	  2:	  Observation	  checklist	  
No	  (as	  in	  the	  questionnaire	  for	  the	  same	  person):................	  
Sex:............	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Age:..............	  	  	  	  	  Position	  at	  clinic:........................	  
1. Health	  worker	  measures	  BP?:	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes	  	  □	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  No	  □ 
2. HW uses what to measure BP: 
               Manuel □     Automatic  □    24-hours monitoring □ 
3. HW	  uses	  which	  	  BP-­‐variable	  as	  a	  result:	  
              Systolic BP □	  	  	  	  	  	  	  	  	  Diastolic	  BP	  □	  	  	  MAP	  □	  	  	  	  Sys/Dia	  BP	  □ 
4. Does the HW measure the BP several times?: 
             Yes □                                 No□ 
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           If yes, how many: 1 extra measurement □    2 extra□   >3 □ 
5. Does the HW take any urin analysis?: 
             Yes □                                No□ 
6. Does the HW give any advice regarding the BP?: 
              Yes □                                 No □ 
              If yes, what sort of advice:.............................................................. 
 
 
7. Any treatment given?: 
             Yes □                                 No□ 
            If yes, what sort of treatment:............................................................ 
	  
	  
7.1.3	  Appendix	  3:	  Inventory	  check	  list	  
1. Number of BP measurement equipments: 
             Manuel:..........    Automatic:.........  24-hours monitoring:......... 
2. Equipment to analyses urin: 
             Yes □                              No□   
If not, where are they send:..................................... 
3. Number of different BP-medication: 
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             ATII-blockers:.......    ACE-blockers:..........    β-blockers:............ 
            Metyl-dopa:..............    Diuretics:............ 
4. Eclaptic medication: 
            Mag.sulphate:.............. 
 
	  
7.1.4	  Appendix	  4:	  Questionnaire	  
Check	  only	  one	  box	  per	  question.	  
Part	  1:	  
1. Sex	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Female	  □         Male □ 
2. Age:................	  
3. Position	  at	  clinic:	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  Doctor	  □  Nurse □   Midwife □  Other □ 
4. How	  long	  have	  you	  worked	  there	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0-­‐5	  years	  □	  	  	  5-­‐10	  years	  □	  	  	  10-­‐15	  years	  □	  	  	  More	  than	  15	  years	  □ 
5. Where	  were	  you	  educated?	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  In	  Tanzania	  □	  	  In	  other	  African	  country	  □	  	  	  In	  Europe	  □	  	  In	  Asia	  □ In	  America	  □   
	  
Part	  2:	  
1. With	  which	  equipment	  do	  you	  measure	  blood	  pressure?	  	  
Automatic	  □   	  Manuel	  □	  	  	  	  	  	  	  	  	  24hour	  monitoring	  □ 
2. Which	  blood	  pressure-­‐variable	  do	  you	  use	  as	  a	  result?	  
	  MAP	  □     	  Systolic	  BP	  □	  	  	  	  	  	  Diastolic	  BP	  □    Sys/Dia BP □ 
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3. When	  do	  you	  measure	  the	  BP	  of	  a	  pregnant	  woman,	  without	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  any	  risk	  factors,	  for	  the	  first	  time?	  






4. How	  often	  do	  you	  measure	  the	  BP	  of	  a	  pregnant	  women	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  without	  any	  risk	  factors?	  
Every	  week	  □	  	  	  	  Every	  month	  □	  	  	  	  	  Every	  trimester	  □	  	  	  
	  Only	  one	  time	  during	  the	  pregnancy	  □	  	  	  	  	  Never	  	  □ 
	  	  	  	  	  	  
5. Are	  there	  any	  supplementary	  tests	  or	  exams	  done	  if	  the	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  women	  has	  high	  BP(	  defined	  here	  as	  160/90)?	  
	  	  	  	  	  …..............................................................................................................	  
6. When	  are	  the	  BP	  considered	  so	  high,	  that	  you	  would	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  initiate	  treatment?	  
Over	  150/100	  □	  	  	  	  	  Over	  160/110	  □	  	  	  	  	  	  	  	  Over	  170/120	  	  □ 
Over	  180/130	  □ 
	  
7. What	  would	  you	  give	  to	  treat	  pre-­‐eclampsi?	  
	  	  	  	  ATII-­‐blockers	  □	  	  	  	  β-­‐blockers	  □	  	  	  	  	  	  ACE-­‐blockers	  □	  	  	  	  	  	  	  
	  	  	  	  Metyldopamin	  □	  	  	  Diuretics	  	  □	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  Other	  	  □	  Please	  specify	  which:.......................	  	  	  	  	  	  	  
	  	  	  	  I	  would	  not	  give	  any	  specific	  medication	  □	  
	  
8. Where	  would	  you	  treat	  a	  pre-­‐eclamptic	  woman	  after	  37th	  week	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  of	  gestation?	  









1. Was	  there	  any	  questions	  that	  were	  unclear?	  If	  yes,	  please,	  write	  the	  number(s)	  of	  
the	  question.	  
…..........................................................................................	  
	  
	  
	  
